This article will discuss Sue's obligations as an agent of the drug company, provide a legal and whistleblower hotline analysis, and give Sue recommended courses of action. In order to do this, this article uses the FILOP guideline as presented in the Browne, Giampetro-Meyer, and Williamson text (2004, pp. 163 - 170). The facts are that Sue, a single mother with two children, was told by her boss to change the numbers on a report going to a federal agency for approval of a new drug. Some missing facts that may help in the analysis are; who are the intended recipients of the drug and what is the purpose of the drug. Should Sue change the numbers on the report as her boss asked to help the company gain approval of the new drug? That is the main issue in this case. Is it legal for Sue's boss to ask her to change the numbers and if Sue does change the numbers who is legally at risk? Sue is in an employer-employee relationship with her boss. As stated in the Kubasek, Brennan, and B...
Comments
Post a Comment